The DBMI Facebook page was launched just in time for a live session about the Master of BIomedical Informatics program, which is accepting applications for Fall of 2018. The deadline to apply is December 4, 2017.
Today we feature Raolat Abdulai, MD, MMSc, who graduated in 2017. She is currently an Associate Director within Early Clinical Development in Respiratory, Inflammation, and Autoimmunity (RIA) therapeutics at AstraZeneca in Waltham, MA.
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.